GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia

    NEXT STORY
    “Medical Practice Income a subsidiary of USA Equities Corp (USAQ), Announces Exclusive Distribution Agreement with MedScience Research Group”
    PREV STORY
    Basilea presents preclinical data on anti-angiogenic activity of derazantinib at ENA 2020
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Basilea initiates targeted biomarker-driven phase 2 study with lisavanbulin in patients with brain cancer

    author_avatar
    NASDAQ Market News

    Immunomedics Reports Sacituzumab Govitecan (IMMU-132) is Active in Patients With Metastatic Small-Cell Lung Cancer Who Are Sensitive or Resistant to First-Line Chemotherapy

    WASHINGTON, April 05, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) ...

    author_avatar
    NASDAQ Market News

    Evelo Biosciences Announces Appointment of Mark Plinio as Chief Commercial Officer

    author_avatar
    NASDAQ Market News